These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34218305)

  • 1. Antidepressant effect of repetitive transcranial magnetic stimulation is not impaired by intake of lithium or antiepileptic drugs.
    Hebel T; Abdelnaim MA; Deppe M; Kreuzer PM; Mohonko A; Poeppl TB; Rupprecht R; Langguth B; Schecklmann M
    Eur Arch Psychiatry Clin Neurosci; 2021 Oct; 271(7):1245-1253. PubMed ID: 34218305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder.
    Zhuo C; Zhou C; Tian H; Li Q; Chen J; Yang L; Zhang Q; Li R; Ma X; Cai Z; Chen G; Xu Y; Song X
    Transl Psychiatry; 2022 Sep; 12(1):359. PubMed ID: 36055984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
    Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
    Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.
    Pinto OC; Akiskal HS
    J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in major depressive disorder: comparing responders and non-responders to Repetitive Transcranial Magnetic Stimulation (rTMS), a naturalistic retrospective chart review.
    Abo Aoun M; Meek BP; Clair L; Wikstrom S; Prasad B; Modirrousta M
    Psychiatry Clin Neurosci; 2023 Jan; 77(1):38-47. PubMed ID: 36207801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated theta burst stimulation for the treatment of depression: A randomised controlled trial.
    Chen L; Thomas EHX; Kaewpijit P; Miljevic A; Hughes R; Hahn L; Kato Y; Gill S; Clarke P; Ng F; Paterson T; Giam A; Sarma S; Hoy KE; Galletly C; Fitzgerald PB
    Brain Stimul; 2021; 14(5):1095-1105. PubMed ID: 34332155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pilot Study of High-Frequency Transcranial Magnetic Stimulation for Bipolar Depression.
    Aaronson ST; Goldwaser EL; Croarkin PE; Geske JR; LeMahieu A; Sklar JH; Kung S
    J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38780536
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in mood stabilizer prescription patterns in bipolar disorder.
    Karanti A; Kardell M; Lundberg U; Landén M
    J Affect Disord; 2016 May; 195():50-6. PubMed ID: 26859073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant lorazepam use and antidepressive efficacy of repetitive transcranial magnetic stimulation in a naturalistic setting.
    Deppe M; Abdelnaim M; Hebel T; Kreuzer PM; Poeppl TB; Langguth B; Schecklmann M
    Eur Arch Psychiatry Clin Neurosci; 2021 Feb; 271(1):61-67. PubMed ID: 32648109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability.
    Chistyakov AV; Kaplan B; Rubichek O; Kreinin I; Koren D; Feinsod M; Klein E
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):223-33. PubMed ID: 15569397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: Session-dependent efficacy: A meta-analysis.
    Teng S; Guo Z; Peng H; Xing G; Chen H; He B; McClure MA; Mu Q
    Eur Psychiatry; 2017 Mar; 41():75-84. PubMed ID: 28049085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression.
    Schulze L; Remington G; Giacobbe P; Kennedy SH; Blumberger DM; Daskalakis ZJ; Downar J
    J Psychopharmacol; 2017 Mar; 31(3):312-319. PubMed ID: 27852961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis.
    Gellersen HM; Kedzior KK
    BMC Psychiatry; 2019 May; 19(1):139. PubMed ID: 31064328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood stabilizers during breastfeeding: a review.
    Chaudron LH; Jefferson JW
    J Clin Psychiatry; 2000 Feb; 61(2):79-90. PubMed ID: 10732654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.